Axion’s MEA systems can model complex brain activity and heartbeats in a dish. As a result, toxicity and efficacy can be assessed earlier in the drug development process, and with greater sensitivity and accuracy. These comprehensive system-level evaluations provide an in vitro solution to reducing animal testing, a key objective of the Tox21 and REACH initiatives.
Axion’s MEA systems provide a label-free in vitro platform for direct measurement of electrical activity in neurons and cardiomyocytes, while the efficiency and convenience of Axion’s standard MEA plates facilitate use for screening-level applications. The large number of electrodes per well reveals detailed information about systems-level signal propogation.
Join Us at SLAS2014
Axion Biosystems will be exhibiting at the 3rd Annual Society for Laboratory Automation & Screening Meeting on January 18-22, 2014. Stop by Booth #1454 in the Exhibit Hall to see our Maestro multiwell microelectrode array (MEA) system.
Visit Meeting Website
Axion Has Moved
Axion is proud to announce that we have outgrown our previous space and have moved to a new location. At double the size of our old location, our brand-new facility features expanded manufacturing and lab areas and more offices for our growing team. You can find us at our new address:
1819 Peachtree Road NE
Atlanta, GA 30309